EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer

Hedvig Elfving, Hui Yu, Kaleab Kassete Fessehatsion, Hans Brunnström, Johan Botling, Miklos Gulyas, Max Backman, Amanda Lindberg, Carina Strell, Patrick Micke

Cellular Oncology · 2025-06 · 48 (3) · 801-813

DOI: 10.1007/s13402-025-01052-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 03.03.2025. Verfasst von Hedvig Elfving und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, 751 85, Sweden. hedvig.elfving@igp.uu.se. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Tertiary Lymphoid Structures, Lung Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Tertiary lymphoid structures (TLS) are lymphocyte aggregates resembling secondary lymphoid organs and are pivotal in cancer immunity. The ambiguous morphological definition of TLS makes it challenging to ascertain their clinical impact on patient survival and response to immunotherapy.

Objectives

This study aimed to characterize TLS in hematoxylin-eosin tissue sections from lung cancer patients, assessing their occurrence in relation to the local immune environment, mutational background, and patient outcome.

Methods

Two pathologists evaluated one whole tissue section from resection specimens of 680 NSCLC patients. TLS were spatially quantified within the tumor area or periphery and further categorized based on the presence of germinal centers (mature TLS). Metrics were integrated with immune cell counts, genomic and transcriptomic data, and correlated with clinical parameters.

Results

TLS were present in 86% of 536 evaluable cases, predominantly in the tumor periphery, with a median of eight TLS per case. Mature TLS were found in 24% of cases. TLS presence correlated positively with increased plasma cell (CD138+) and lymphocytic cell (CD3+, CD8+, FOXP3+) infiltration. Tumors with higher tumor mutational burden exhibited higher numbers of peripheral TLS. The overall TLS quantity was independently associated with improved patient survival, irrespective of TLS maturation status. This prognostic association held true for peripheral TLS but not for tumor TLS.

Conclusion

TLS in NSCLC is common and their correlation with a specific immune phenotype suggests biological relevance in the local immune reaction. The prognostic significance of this scoring system on routine hematoxylin-eosin sections has the potential to augment diagnostic algorithms for NSCLC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungTertiary Lymphoid StructuresLung NeoplasmsHumansMaleFemaleMiddle AgedAgedMutationPrognosisTumor MicroenvironmentAged, 80 and overLymphocytes, Tumor-Infiltrating

Stichwörter der Autor:innen

Immune microenvironmentImmunotherapyLymphocytesPrognosisTumor microenvironment

Autor:innen und Institutionen

  • Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, 751 85, Sweden. hedvig.elfving@igp.uu.se.
  • Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, 751 85, Sweden.
  • Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Förderung

  • Uppsala University

Zitieren

APA

Elfving, H., Yu, H., Fessehatsion, K. K., Brunnström, H., Botling, J., Gulyas, M., Backman, M., Lindberg, A., Strell, C., & Micke, P. (2025). Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer. Cellular Oncology, 48(3), 801-813. https://doi.org/10.1007/s13402-025-01052-x

Vancouver

Elfving H, Yu H, Fessehatsion KK, Brunnström H, Botling J, Gulyas M, et al. Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer. Cellular Oncology. 2025;48(3):801-813. doi:10.1007/s13402-025-01052-x

BibTeX
@article{Elfving2025,
  author = {Elfving, Hedvig and Yu, Hui and Fessehatsion, Kaleab Kassete and Brunnström, Hans and Botling, Johan and Gulyas, Miklos and Backman, Max and Lindberg, Amanda and Strell, Carina and Micke, Patrick},
  title = {Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer},
  journal = {Cellular Oncology},
  year = {2025},
  volume = {48},
  number = {3},
  pages = {801--813},
  doi = {10.1007/s13402-025-01052-x}
}
Kostenlos starten →